OptimizeRx
OPRX
180 hedge funds and large institutions have $930M invested in OptimizeRx in 2021 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 61 increasing their positions, 49 reducing their positions, and 40 closing their positions.
61% more call options, than puts
Call options by funds: $62.9M | Put options by funds: $39M
45% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 40
24% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 49
10% more funds holding
Funds holding: 163 → 180 (+17)
5.62% more ownership
Funds ownership: 78.77% → 84.39% (+5.6%)
22% less capital invested
Capital invested by funds: $1.19B → $930M (-$256M)
58% less funds holding in top 10
Funds holding in top 10: 12 → 5 (-7)
Top Buyers
| 1 |
BlackRock
New York
|
+$118M |
| 2 |
State Street
Boston,
Massachusetts
|
+$21.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.9M |
| 5 |
Morgan Stanley
New York
|
+$12.5M |
Top Sellers
OPRX Hedge Fund Activity: Q4 2021 in Review
180 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q4 2021, worth a combined $930M — down 22% from $1.19B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new OPRX positions and 40 closed out — a net gain of 18 holders — while 61 added to existing stakes and 49 trimmed.
The largest buyer was BlackRock, adding an estimated $118M. The largest seller was Millennium Management, cutting an estimated $43.9M.
- 180 institutional investors held OptimizeRx (OPRX) as of Q4 2021, up from 163 in Q3 2021.
- Funds reported $930M of OptimizeRx stock for Q4 2021, down 22% quarter-over-quarter.
- 58 funds opened new OptimizeRx positions in Q4 2021 and 40 closed out, a net change of +18 holders.
- The largest OptimizeRx buyer in Q4 2021 was BlackRock, an estimated $118M added.
- The largest OptimizeRx seller in Q4 2021 was Millennium Management, an estimated $43.9M sold.
Based on aggregated 13F filings for Q4 2021.